Nonketotic hyperglycinemia (glycine encephalopathy): laboratory diagnosis.

Article Details

Citation

Applegarth DA, Toone JR

Nonketotic hyperglycinemia (glycine encephalopathy): laboratory diagnosis.

Mol Genet Metab. 2001 Sep-Oct;74(1-2):139-46.

PubMed ID
11592811 [ View in PubMed
]
Abstract

Nonketotic hyperglycinemia (NKH) is an autosomal recessive disorder of glycine metabolism caused by a defect in the glycine cleavage enzyme complex (GCS). GCS is a complex of four proteins encoded on four different chromosomes. In classical neonatal NKH, levels of cerebrospinal fluid (CSF) glycine and CSF/plasma glycine ratio are very high but the CSF results, in particular, may be more difficult to interpret in later-onset, milder, or otherwise atypical NKH. Enzymatic confirmation of NKH requires a liver sample. Delineation of which protein of the complex is defective is necessary to screen for mutations in the appropriate gene. Except for Finnish NKH patients, few recurrent mutations have yet been found, although analysis of the P-protein gene (the site of the defect in the majority of patients) is at an early stage. Prenatal diagnosis by GCS assay in chorionic villus biopsies is not completely reliable and will be replaced by molecular analysis in families where the mutations are known.

DrugBank Data that Cites this Article

Polypeptides
NameUniProt ID
Glycine dehydrogenase (decarboxylating), mitochondrialP23378Details